Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

597
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
597
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

387
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
387
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

362
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
362
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NIH Funding for Artificial Intelligence in Surgical Specialties: Allocation and Alignment with US Disease Burden.

Journal of the American College of Surgeons·2026
Same author

Large Language Models Provide Accurate but Potentially Unsafe Answers to Multimodal Critical Care Medicine Board Review Questions.

Critical care medicine·2026
Same author

Moving beyond the benchmarks: Five foundational principles for meaningful AI evaluation in healthcare.

PLOS digital health·2026
Same author

Can AI Say "I Don't Know"?

The New England journal of medicine·2026
Same author

Evidence, transparency, and scope: concerns about Doctronic.

BMJ (Clinical research ed.)·2026
Same author

Integrating natural language processing into radiation oncology: a practical guide to transformer architecture and large language models.

BJR artificial intelligence·2026

Related Experiment Video

Updated: Apr 26, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

15.4K

A data-driven approach to optimized medication dosing: a focus on heparin.

Mohammad M Ghassemi1, Stefan E Richter, Ifeoma M Eche

  • 1Laboratory for Computational Physiology, Massachusetts Institute of Technology, E25-505, 77 Massachusetts Ave, Cambridge, 02139, MA, USA, ghassemi@mit.edu.

Intensive Care Medicine
|August 6, 2014
PubMed
Summary

This study introduces a new method using patient data to optimize heparin dosing, improving therapeutic outcomes compared to standard weight-based methods. This approach enhances drug safety and effectiveness for medications with narrow therapeutic windows.

More Related Videos

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

601
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

15.4K
Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

601
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

Area of Science:

  • Pharmacology
  • Medical Informatics
  • Biostatistics

Background:

  • Medications with sensitive therapeutic windows, like unfractionated heparin, are often misdosed.
  • Current dosing strategies, such as weight-based heparin dosing, do not fully account for individual patient variability.
  • Optimizing drug dosage is crucial for maximizing efficacy and minimizing adverse events.

Purpose of the Study:

  • To develop and demonstrate a novel method for creating statistically optimal dosing strategies using retrospective health data.
  • To apply this method to intravenous unfractionated heparin, addressing its frequent misdosing.
  • To improve the precision of drug administration for medications requiring careful therapeutic level management.

Main Methods:

  • Utilized retrospective data from 1,511 intensive care unit patients.
  • Developed multivariate logistic regressions to model sub- and supra-therapeutic activated partial thromboplastin time (aPTT) based on clinical features.
  • Estimated initial heparin doses to maximize the probability of achieving a therapeutic aPTT within 4-8 hours.
  • Compared the model's classification performance against a weight-alone alternative using volume under surface (VUS).

Main Results:

  • Identified significant associations between aPTT levels and factors including race, ICU type, gender, heparin dose, age, and Sequential Organ Failure Assessment scores.
  • Achieved mean validation AUC values of 0.78 and 0.79 for the logistic regression models.
  • The novel dosing model demonstrated superior outcome classification compared to the weight-alone method, with VUS values of 0.48 versus 0.42.

Conclusions:

  • This research highlights the potential of secondary health data analysis for optimizing drug dosing strategies.
  • The developed method offers a statistically robust approach to personalized medication management.
  • Further validation through randomized controlled trials is recommended to confirm improved aPTT achievement compared to current weight-based heparin dosing.